Effects of tiotropium bromide combined with montelukast on blood rheology, pulmonary function and serum cytokine levels in patients with chronic obstructive pulmonary disease
Lists
Only you see this
Abstract
Objective: To explore the effect of tiotropium bromide combined with montelukast on COPD \npatients’ blood rheology, pulmonary function and serum cytokine levels. Methods: A total \nof 82 COPD patients who were treated in our hospital from June 2015 to January 2016 were \ndivided into control group and observation group randomly by half. All patients were given \nsymptomatic and conventional treatment according to the specific circumstances, patients in \nthe control group were treated with 10 mg montelukast with orally once per night on the basis \nof conventional treatment, and observation group patients was given 18 μg tiotropium bromide \ninhalation once per night on the basis of control group. All the patients were treated for 4 \nweeks, the blood rheology indexes, pulmonary function indexes and serum cytokines were \nmeasured and compared between the two groups before and after treatment. Results: Before \ntreatment, there was no significant difference in blood rheology index of whole blood viscosity \n(high shear viscosity, shear viscosity, low shear viscosity), plasma viscosity, hematocrit and \nfibrinogen (P>0.05); After treatment, the blood rheology indexes of the two groups were \nsignificantly decreased compared with that in the same group before treatment (P<0.05). \nMeanwhile, the related indexes of blood rheology in observation group were significantly \nbetter than the control group (P<0.05). Before treatment, there was no significant difference \nin Lung function indexes of FVC, FEV1, MMEF, PEF (P>0.05). After treatment, the indexes \nof pulmonary function in the two groups were significantly higher than that in the same group \nbefore treatment (P<0.05). Meanwhile, the level of lung function in the observation group \nwere significantly higher than that in the control group (P<0.05). Before treatment, there was \nno significant difference in cell factors of serum IL-10, IL-18, APN (P>0.05); After treatment, \nthe two groups’ serum IL-10, APN levels were significantly increased, IL-18 levels were \nsignificantly reduced (P<0.05). Meanwhile, serum IL-10, APN levels in Observation group \nwere significantly increased, IL-18 levels were significantly lower than that in control group \n(P<0.05). Conclusions: The comibinition of tiotropium bromide with montelukas not only can \nimprove the indexes of blood rheology in patients with COPD, and can significantly control the \nlevel of serum cytokines and control symptoms, improve lung function, so it is worth further \nclinical application.
BibTeX
@inproceedings{meng2016effects,
author = {Qinghua Meng and Chenghong Li and Xiaojiang Wang and Yi Shi and Qiong Feng},
title = {{Effects of tiotropium bromide combined with montelukast on blood rheology, pulmonary function and serum cytokine levels in patients with chronic obstructive pulmonary disease}},
booktitle = {SHILAP},
year = {2016},
}Loading related content...